Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer
- 1 January 1996
- Vol. 47 (1) , 34-37
- https://doi.org/10.1016/s0090-4295(99)80378-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Content of Urokinase-Type Plasminogen Activator and Tumor Recurrence in Superficial Bladder CancerJournal of Urology, 1994
- Plasminogen Activators: Regulators of Tumor Cell Adherence to Sites of Lower Urinary Tract Surgical TraumaJournal of Urology, 1993
- The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancerInternational Journal of Cancer, 1992
- Neoadjuvant M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Effect on the Primary Bladder LesionJournal of Urology, 1988
- Plasminogen activator in bladder tumorsUrological Research, 1987
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- Fibrinolytic activity of in vitro cultivated human bladder cell linesUrological Research, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Superficial bladder tumor: Aspects of clinical progressionUrology, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958